Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001472433-24-000001
Filing Date
2024-07-26
Accepted
2024-07-26 16:19:24
Documents
1
Effectiveness Date
2024-07-26
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6319
  Complete submission text file 0001472433-24-000001.txt   7514
Mailing Address 111 CENTRAL PARK NORTH SUITE 18A NEW YORK NY 10026
Business Address 111 CENTRAL PARK NORTH SUITE 18A NEW YORK NY 10026 212-924-3800
Wyvern Medical Fund LP (Filer) CIK: 0001472433 (see all company filings)

EIN.: 270897593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-182341 | Film No.: 241147203